Posts in category Business Standard
Benchmarks near falt line; realty shares under pressure (22-07-2024)
At 11:30 IST, the barometer index, the S&P BSE Sensex, was down 42.17 points or 0.06% to 80,551.92. The Nifty 50 index shed 3.75 points or 0.02% to 24,527.15
Harsh Goenka-backed RPG Life Sciences surges 15% on solid Q1FY25 results (22-07-2024)
Shares of small cap firm RPG Life Sciences surged up to 14.81 per cent, hitting its 52-week high at Rs 2057.15 per share on the BSE in Monday's intraday deals
SBI Fund sees Union Budget 2024 arming Reserve Bank with liquidity tool (22-07-2024)
MSS bonds are issued by the government outside the normal borrowing program to enable the Reserve Bank of India soak up liquidity
Indian Hotels rallies Q1 PAT climbs 10% YoY to Rs 260 crore (22-07-2024)
Indian Hotels Company (IHCL) jumped 5.79% to Rs 610.65 after the company's consolidated net profit rose 11.67% to Rs 248.39 crore on 5.72% increase in revenue from operations to Rs 1,550.23 crore in Q1 FY25 over Q1 FY24.
YES Bank surges 5% after Q1FY25 profit rises 47%, provisions fall 41% (22-07-2024)
The jump in the stock price came on the back of strong June quarter results (Q1FY25).
LIC stock is up 16% in July on the BSE; what’s fueling the rise? Check here (22-07-2024)
Analysts remain optimistic about the medium-term outlook for the life insurance sector, and expect Retail APE to grow ~12-13 per cent during FY25E.
PVR INOX Q1 net loss widens to Rs 179 cr (22-07-2024)
The cinema chain operator's consolidated net loss widened to Rs 179 crore in Q1 FY25 from a net loss of Rs 82 crore recorded in Q1 FY24.
Volumes soar at Oberoi Realty Ltd counter (22-07-2024)
Oberoi Realty Ltd recorded volume of 56300 shares by 10:47 IST on BSE, a 4.31 times surge over two-week average daily volume of 13048 shares
Zydus Lifes gains after receiving approval from COFEPRIS for Bevacizumab biosimilar (22-07-2024)
Zydus Lifesciences rose 1.52% to Rs 1161.95 after the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) granted marketing approval to the company for Bhava, a Bevacizumab biosimilar.
RNFI Services IPO opens today: Check GMP, Dates, Price, Size and more (22-07-2024)
The RNFI Services IPO comprises a fresh issue of 6,744,000 shares aggregating up to Rs 70.8 crore and is available at a price band of Rs 98-105 per share